47045-SWZ-H-NERCHA-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Reduction of HIV in Swaziland - Eswatini (01-Oct-2015-30-Sep-2018)</narrative> Eswatini, HIV, National Emergency Response Council on HIV and AIDS Goals: Ensuring adequate health systems to support the attainment of health service targets, especially relating to HIV/AIDS, TB and Malaria; Halt the spread of HIV and reverse its impact in Swazi society. Objectives: HIV - 50% reduction of new HIV infections among adults by 2015; HIV - 90% reduction of new HIV infections among infants aged 18 - 24 months born to HIV positive mothers by 2015; HIV - alleviate the socio-economic impacts of HIV and AIDS among vulnerable groups and across the population in general; HIV - avert 15% deaths amongst PLHIV and in particular those with TB/HIV co-infection; HIV - improve efficiency and effectiveness of the national response; HIV - reduction of proportion of young people 15 - 24 who are living with HIV from 6% to 2% for men and from 23% to 10% for women by 2018 respectively; HSS - to build capacity of human resources for health with a focus on supply chain management, community health services and health information systems; HSS - to implement the computerised Client Management Information System (CMIS), provide infrastucture and equipment to link the different sources of information and to build capacity for analysis and use of health information; HSS - to improve the health products procurement and supply chain management systems, and monitoring of rational use of health products in the country; HSS - to roll out service delivery systems across the country - specifically closing gaps in supervision systems, outreach services provision, referral services, and infrastructure and equipment needed to organize and manage the provision of care. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS National Emergency Response Council on HIV and AIDS The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Eswatini HIV Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 19935237.00 Global Fund commitment to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 9893338.00 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 8452093.30 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 521739.00 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS -1068066.70 Global Fund commitment to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 16788257.00 Global Fund commitment to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 6645559.00 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 8449388.00 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 213261.00 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 1103549.00 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS -376500.00 Global Fund commitment to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 2378371.00 Global Fund commitment to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 2113555.00 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS 264816.00 Global Fund disbursement to SWZ-H-NERCHAP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria National Emergency Response Council on HIV and AIDS <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 9280; Denominator: 10308. Numerator: 5202; Denominator: 5476. Numerator: 5063; Denominator: 5330. Numerator: 10127; Denominator: 10660. Numerator: 4896; Denominator: 5154. Numerator: 4520; Denominator: 4762. Numerator: 9792; Denominator: 10307. Numerator: 9202; Denominator: 9902. Numerator: 4718; Denominator: 4966. Numerator: 0; Denominator: 9932. Numerator: 7077; Denominator: 7449. Numerator: 6834; Denominator: 9932. <narrative>Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth</narrative> Module: PMTCT. <narrative>Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 8777; Denominator: 9038. Numerator: 5312; Denominator: 5476. Numerator: 5223; Denominator: 5330. Numerator: 10447; Denominator: 10660. Numerator: 5102; Denominator: 5154. Numerator: 3977; Denominator: 4323. Numerator: 10204; Denominator: 10307. Numerator: 8286; Denominator: 8597. Numerator: 4916; Denominator: 4966. Numerator: 5130; Denominator: 9932. Numerator: 7375; Denominator: 7449. Numerator: 7346; Denominator: 9932. <narrative>Percentage of pregnant women who know their HIV status</narrative> Module: PMTCT. <narrative>Percentage of pregnant women who know their HIV status</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 30921; Denominator: 34357. Numerator: 16421; Denominator: 17286. Numerator: 15669; Denominator: 16494. Numerator: 31338; Denominator: 32988. Numerator: 16537; Denominator: 17407. Numerator: 14251; Denominator: 15910. Numerator: 33073; Denominator: 34814. Numerator: 30506; Denominator: 31659. Numerator: 16548; Denominator: 17419. Denominator: 14456. Numerator: 24822; Denominator: 26129. Numerator: 7332; Denominator: 9932. <narrative>Number of medical male circumcisions performed according to national standards</narrative> Module: Prevention programs for general population. <narrative>Number of medical male circumcisions performed according to national standards</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Percentage: 32.2%. Numerator: 625; Denominator: 41854; Percentage: 1.5%. Numerator: 1875; Denominator: 41854; Percentage: 4.5%. Numerator: 4750; Denominator: 45543; Percentage: 10.4%. Numerator: 7000; Denominator: 45543; Percentage: 15.4%. Numerator: 1721; Denominator: 45534; Percentage: 3.8%. Numerator: 9250; Denominator: 49165; Percentage: 18.8%. Numerator: 1508; Denominator: 49165; Percentage: 3.1%. Numerator: 11500; Denominator: 49165; Percentage: 23.4%. Numerator: 3305. Numerator: 12625; Denominator: 52986; Percentage: 23.8%. Numerator: 3376; Denominator: 52986; Percentage: 6.4%. <narrative>Proportion of facility reports received over the reports expected during the reporting period</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Proportion of facility reports received over the reports expected during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 134; Denominator: 223; Percentage: 60%. Numerator: 133; Denominator: 133; Percentage: 100%. Numerator: 133; Denominator: 133; Percentage: 100%. Numerator: 133; Denominator: 133; Percentage: 100%. Numerator: 133; Denominator: 133; Percentage: 100%. Numerator: 164; Denominator: 237; Percentage: 69.2%. Numerator: 133; Denominator: 133; Percentage: 100%. Numerator: 130; Denominator: 224; Percentage: 58%. Numerator: 133; Denominator: 133; Percentage: 100%. Numerator: 0; Denominator: 0. Numerator: 133; Denominator: 133; Percentage: 100%. <narrative>HSS PSM-other 1: Percent of health facilities experiencing a stock-out of at least one required ARV drug</narrative> Module: RSSH: Health products management systems. <narrative>HSS PSM-other 1: Percent of health facilities experiencing a stock-out of at least one required ARV drug</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 215; Denominator: 287. Numerator: 7; Denominator: 133. Numerator: 5; Denominator: 133. Numerator: 4; Denominator: 133. Numerator: 3; Denominator: 133. Numerator: 0; Denominator: 165. Numerator: 2; Denominator: 133. Numerator: 10; Denominator: 41. Numerator: 0; Denominator: 133. Numerator: 17; Denominator: 43. Numerator: 0; Denominator: 133. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 100138; Denominator: 208070. Numerator: 105572; Denominator: 211144. Numerator: 106760; Denominator: 213520. Numerator: 117436; Denominator: 213520. Numerator: 129205; Denominator: 215341. Numerator: 130965; Denominator: 131530. Numerator: 139972; Denominator: 215341. Numerator: 123731; Denominator: 124152. Numerator: 151723; Denominator: 216747. Numerator: 150362; Denominator: 162278. Numerator: 158225; Denominator: 216747. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 3123; Denominator: 3972. Numerator: 3973; Denominator: 4845. Numerator: 2482; Denominator: 2920. Numerator: 4963; Denominator: 5839. Numerator: 3019; Denominator: 3355. Numerator: 939; Denominator: 1015. Numerator: 6039; Denominator: 6710. Numerator: 2059.54; Denominator: 2191. Numerator: 3629; Denominator: 3820. Numerator: 838; Denominator: 839. Numerator: 5444; Denominator: 5730. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 5430; Denominator: 5582. Numerator: 6637; Denominator: 6842. Numerator: 4171; Denominator: 4256. Numerator: 8342; Denominator: 8512. Numerator: 5007; Denominator: 5058. Numerator: 1476; Denominator: 1519. Numerator: 10015; Denominator: 10116. Numerator: 3166; Denominator: 3226. Numerator: 5877; Denominator: 5936. Numerator: 1272; Denominator: 1278. Numerator: 8815; Denominator: 8904. Numerator: 2053; Denominator: 2073. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 125421; Denominator: 208070. Numerator: 145590; Denominator: 211144. Numerator: 153734; Denominator: 213520. Numerator: 160140; Denominator: 213520. Numerator: 172273; Denominator: 215341. Numerator: 172184; Denominator: 231610. Numerator: 185193; Denominator: 215341. Numerator: 174103; Denominator: 231610. Numerator: 193113; Denominator: 216747. Numerator: 162278; Denominator: 206402. Numerator: 197240; Denominator: 216747. Numerator: 172904; Denominator: 206402.